Amgen Inc. buy Royal Bank of Canada
Start price
15.01.26
/
50%
€284.25
Target price
15.01.27
€287.83
Performance (%)
-2.78%
Price
20.01.26
€282.60
Summary
This prediction is currently active. With a performance of -2.78%, the BUY prediction for Amgen Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 15.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Amgen Inc. | -2.78% |
| iShares Core DAX® | -3.141% |
| iShares Nasdaq 100 | -3.518% |
| iShares Nikkei 225® | -3.396% |
| iShares S&P 500 | -2.943% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $335.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat